Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 13

1.

Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI).

Siddiqi N, Bruce M, Neil CJ, Jagpal B, Maclennon G, Cotton SC, Papadopoulo SA, Bunce N, Lim P, Schwarz K, Singh S, Hildick-Smith D, Horowitz JD, Madhani M, Boon N, Kaski JC, Dawson D, Frenneaux MP.

J Transl Med. 2013 May 6;11:116. doi: 10.1186/1479-5876-11-116.

2.

The randomised Complete versus Lesion-only PRimary percutaneous coronary Intervention Trial: Cardiovascular Magnetic Resonance imaging substudy (CvLPRIT-CMR).

McCann GP, Khan JN, Greenwood JP, Nazir SA, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH.

Southampton (UK): NIHR Journals Library; 2016 Jan.

3.
4.

The impact of ischemia-reperfusion injury on the effectiveness of primary angioplasty in ST-segment elevation myocardial infarction.

Araszkiewicz A, Grygier M, Lesiak M, Grajek S.

Postepy Kardiol Interwencyjnej. 2013;9(3):275-81. doi: 10.5114/pwki.2013.37509. Epub 2013 Sep 16. Review.

5.

Cardiovascular magnetic resonance T2-weighted imaging of myocardial edema in acute myocardial infarction.

Abdel-Aty H, Schulz-Menger J.

Recent Pat Cardiovasc Drug Discov. 2007 Jan;2(1):63-8. Review.

PMID:
18221104
6.

Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.

Montecucco F, Carbone F, Schindler TH.

Eur Heart J. 2016 Apr 21;37(16):1268-83. doi: 10.1093/eurheartj/ehv592. Epub 2015 Nov 4. Review.

PMID:
26543047
7.

Reducing myocardial infarct size: challenges and future opportunities.

Bulluck H, Yellon DM, Hausenloy DJ.

Heart. 2016 Mar 1;102(5):341-8. doi: 10.1136/heartjnl-2015-307855. Epub 2015 Dec 16. Review.

8.

Pharmacologic therapy for reducing myocardial infarct size in clinical trials: failed and promising approaches.

Sattur S, Brener SJ, Stone GW.

J Cardiovasc Pharmacol Ther. 2015 Jan;20(1):21-35. doi: 10.1177/1074248414540799. Epub 2014 Jul 1. Review.

PMID:
24986835
9.

Cardioprotection for percutaneous coronary intervention--reperfusion quality as well as quantity.

Giblett JP, West NE, Hoole SP.

Int J Cardiol. 2014 Dec 20;177(3):786-93. doi: 10.1016/j.ijcard.2014.10.041. Epub 2014 Oct 22. Review.

PMID:
25453404
10.

Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury.

Fordyce CB, Gersh BJ, Stone GW, Granger CB.

Trends Pharmacol Sci. 2015 Sep;36(9):605-16. doi: 10.1016/j.tips.2015.06.004. Epub 2015 Jul 3. Review.

PMID:
26148636
11.

Oxygen in the Setting of Acute Myocardial Infarction: Is It Really a Breath of Fresh Air?

Loomba RS, Nijhawan K, Aggarwal S, Arora RR.

J Cardiovasc Pharmacol Ther. 2016 Mar;21(2):143-9. doi: 10.1177/1074248415598004. Epub 2015 Aug 3. Review.

PMID:
26240074
12.

Role of T-cells in myocardial infarction.

Hofmann U, Frantz S.

Eur Heart J. 2016 Mar 14;37(11):873-9. doi: 10.1093/eurheartj/ehv639. Epub 2015 Dec 8. Review.

PMID:
26646702
13.

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.

Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, Kloner RA, Ovize M, Yellon DM, Garcia-Dorado D.

Eur Heart J. 2016 Apr 26. pii: ehw145. [Epub ahead of print] Review. No abstract available.

PMID:
27118196
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk